8-K//Current report
X4 Pharmaceuticals, Inc 8-K
Accession 0001628280-23-040050
$XFORCIK 0001501697operating
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 5:20 PM ET
Size
158.7 KB
Accession
0001628280-23-040050
Documents
- 8-Kxfor-20231127.htmPrimary
8-K
- EX-101.SCHxfor-20231127.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABxfor-20231127_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PRExfor-20231127_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLxfor-20231127_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001628280-23-040050-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001501697
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 26, 7:00 PM ET
- Accepted
- Nov 27, 5:20 PM ET
- Size
- 158.7 KB